BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bernstein D, Fajardo G, Zhao M. THE ROLE OF β-ADRENERGIC RECEPTORS IN HEART FAILURE: DIFFERENTIAL REGULATION OF CARDIOTOXICITY AND CARDIOPROTECTION. Prog Pediatr Cardiol 2011;31:35-8. [PMID: 21765627 DOI: 10.1016/j.ppedcard.2010.11.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Vyas FS, Nelson CP, Dickenson JM. Role of transglutaminase 2 in A1 adenosine receptor- and β2-adrenoceptor-mediated pharmacological pre- and post-conditioning against hypoxia-reoxygenation-induced cell death in H9c2 cells. Eur J Pharmacol 2018;819:144-60. [PMID: 29208472 DOI: 10.1016/j.ejphar.2017.11.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Sogunmez N, Akten ED. Intrinsic Dynamics and Causality in Correlated Motions Unraveled in Two Distinct Inactive States of Human β2-Adrenergic Receptor. J Phys Chem B 2019;123:3630-42. [PMID: 30946584 DOI: 10.1021/acs.jpcb.9b01202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Klevstig M, Manakov D, Kasparova D, Brabcova I, Papousek F, Zurmanova J, Zidek V, Silhavy J, Neckar J, Pravenec M, Kolar F, Novakova O, Novotny J. Transgenic rescue of defective Cd36 enhances myocardial adenylyl cyclase signaling in spontaneously hypertensive rats. Pflugers Arch 2013;465:1477-86. [PMID: 23636771 DOI: 10.1007/s00424-013-1281-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
4 Kumari N, Gaur H, Bhargava A. Cardiac voltage gated calcium channels and their regulation by β-adrenergic signaling. Life Sci 2018;194:139-49. [PMID: 29288765 DOI: 10.1016/j.lfs.2017.12.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
5 Jhun BS, O-Uchi J, Adaniya SM, Cypress MW, Yoon Y. Adrenergic Regulation of Drp1-Driven Mitochondrial Fission in Cardiac Physio-Pathology. Antioxidants (Basel) 2018;7:E195. [PMID: 30567380 DOI: 10.3390/antiox7120195] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
6 Strohman MJ, Maeda S, Hilger D, Masureel M, Du Y, Kobilka BK. Local membrane charge regulates β2 adrenergic receptor coupling to Gi3. Nat Commun 2019;10:2234. [PMID: 31110175 DOI: 10.1038/s41467-019-10108-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 16.5] [Reference Citation Analysis]
7 Zhang J, Cai WK, Zhang Z, Wang P, Lin XQ, Feng J, Fu SC, He GH. Cardioprotective effect of histamine H2 antagonists in congestive heart failure: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e0409. [PMID: 29642208 DOI: 10.1097/MD.0000000000010409] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Tibenska V, Benesova A, Vebr P, Liptakova A, Hejnová L, Elsnicová B, Drahota Z, Hornikova D, Galatík F, Kolar D, Vybiral S, Alánová P, Novotný J, Kolar F, Novakova O, Zurmanova JM. Gradual cold acclimation induces cardioprotection without affecting β-adrenergic receptor-mediated adenylyl cyclase signaling. Journal of Applied Physiology 2020;128:1023-32. [DOI: 10.1152/japplphysiol.00511.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ali DC, Naveed M, Gordon A, Majeed F, Saeed M, Ogbuke MI, Atif M, Zubair HM, Changxing L. β-Adrenergic receptor, an essential target in cardiovascular diseases. Heart Fail Rev 2020;25:343-54. [PMID: 31407140 DOI: 10.1007/s10741-019-09825-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
10 Reeks TA, Fry BG, Alewood PF. Privileged frameworks from snake venom. Cell Mol Life Sci 2015;72:1939-58. [DOI: 10.1007/s00018-015-1844-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
11 Nakib I, Martin-Eauclaire MF, Laraba-Djebari F. Involvement of Cholinergic and Adrenergic Receptors in Pathogenesis and Inflammatory Response Induced by Alpha-Neurotoxin Bot III of Scorpion Venom. Inflammation 2016;39:1670-80. [PMID: 27395044 DOI: 10.1007/s10753-016-0401-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
12 Kayki-mutlu G, Karaomerlioglu I, Arioglu-inan E, Altan VM. Beta-3 adrenoceptors: A potential therapeutic target for heart disease. European Journal of Pharmacology 2019;858:172468. [DOI: 10.1016/j.ejphar.2019.172468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rossano JW, Shaddy RE. Update on Pharmacological Heart Failure Therapies in Children: Do Adult Medications Work in Children and if Not, Why Not? Circulation 2014;129:607-12. [DOI: 10.1161/circulationaha.113.003615] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
14 Calderón-Zamora L, Canizalez-Román A, León-Sicairos N, Aguilera-Mendez A, Huang F, Hong E, Villafaña S. Changes in expression of orphan receptors GPR99 and GPR107 during the development and establishment of hypertension in spontaneously hypertensive rats. J Recept Signal Transduct Res 2020;:1-8. [PMID: 33121311 DOI: 10.1080/10799893.2020.1835959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Rossano JW, Cabrera AG, Jefferies JL, Naim MP, Humlicek T. Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Chronic Heart Failure. Pediatr Crit Care Med 2016;17:S20-34. [PMID: 26945326 DOI: 10.1097/PCC.0000000000000624] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
16 Li YF, Jiang ZL, Cao FF, Liu F. Effects of olmesartan therapy on the expression of lung adrenoceptors in rats with chronic heart failure. J Renin Angiotensin Aldosterone Syst 2015;16:6-12. [PMID: 25487981 DOI: 10.1177/1470320314557848] [Reference Citation Analysis]
17 Sánchez-villamil JP, D’annunzio V, Finocchietto P, Holod S, Rebagliati I, Pérez H, Peralta JG, Gelpi RJ, Poderoso JJ, Carreras MC. Cardiac-specific overexpression of thioredoxin 1 attenuates mitochondrial and myocardial dysfunction in septic mice. The International Journal of Biochemistry & Cell Biology 2016;81:323-34. [DOI: 10.1016/j.biocel.2016.08.045] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
18 Ghigo A, Li M, Hirsch E. New signal transduction paradigms in anthracycline-induced cardiotoxicity. Biochim Biophys Acta 2016;1863:1916-25. [PMID: 26828775 DOI: 10.1016/j.bbamcr.2016.01.021] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 18.4] [Reference Citation Analysis]
19 Kilian LS, Frank D, Rangrez AY. RhoA Signaling in Immune Cell Response and Cardiac Disease. Cells 2021;10:1681. [PMID: 34359851 DOI: 10.3390/cells10071681] [Reference Citation Analysis]
20 Schranz D, Voelkel NF. "Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr 2016;175:445-55. [PMID: 26895877 DOI: 10.1007/s00431-016-2700-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
21 Kondrashov A, Mohd Yusof NAN, Hasan A, Goulding J, Kodagoda T, Hoang DM, Vo NTN, Melarangi T, Dolatshad N, Gorelik J, Hill SJ, Harding SE, Denning C. CRISPR/Cas9-mediated generation and analysis of N terminus polymorphic models of β2AR in isogenic hPSC-derived cardiomyocytes. Mol Ther Methods Clin Dev 2021;20:39-53. [PMID: 33335946 DOI: 10.1016/j.omtm.2020.10.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Rossano JW, Jang GY. Pediatric heart failure: current state and future possibilities. Korean Circ J 2015;45:1-8. [PMID: 25653697 DOI: 10.4070/kcj.2015.45.1.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kang J, More KN, Pyo A, Jung Y, Kim DY, Chang DJ. Bisoprolol-based 18F-PET tracer: Synthesis and preliminary in vivo validation of β1-blocker selectivity for β1-adrenergic receptors in the heart. Bioorg Med Chem Lett 2021;36:127789. [PMID: 33453362 DOI: 10.1016/j.bmcl.2021.127789] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Recla S, Schmidt D, Logeswaran T, Esmaeili A, Schranz D. Pediatric heart failure therapy: why β1-receptor blocker, tissue ACE-I and mineralocorticoid-receptor-blocker? Transl Pediatr 2019;8:127-32. [PMID: 31161079 DOI: 10.21037/tp.2019.04.08] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Wilkinson JD, Westphal JA, Bansal N, Czachor JD, Razoky H, Lipshultz SE. Lessons learned from the Pediatric Cardiomyopathy Registry (PCMR) Study Group. Cardiol Young 2015;25:140-53. [DOI: 10.1017/s1047951115000943] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
26 Singh I, Rahaghi FN, Naeije R, Oliveira RKF, Systrom DM, Waxman AB. Right Ventricular-Arterial Uncoupling During Exercise in Heart Failure With Preserved Ejection Fraction: Role of Pulmonary Vascular Dysfunction. Chest 2019;156:933-43. [PMID: 31103695 DOI: 10.1016/j.chest.2019.04.109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
27 Bellavite P, Signorini A, Marzotto M, Moratti E, Bonafini C, Olioso D. Cell sensitivity, non-linearity and inverse effects. Homeopathy 2015;104:139-60. [DOI: 10.1016/j.homp.2015.02.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
28 Martin A, Hancox RJ, Chang CL, Beasley R, Wrobel J, McDonald V, Dobler CC, Yang IA, Farah CS, Cochrane B, Hillis GS, Scowcroft CP, Aggarwal A, Di Tanna GL, Balicki G, Galgey S, Jenkins C. Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD. BMJ Open 2021;11:e053446. [PMID: 34452971 DOI: 10.1136/bmjopen-2021-053446] [Reference Citation Analysis]
29 Vallorz EL, Blohm-Mangone K, Schnellmann RG, Mansour HM. Formoterol PLGA-PEG Nanoparticles Induce Mitochondrial Biogenesis in Renal Proximal Tubules. AAPS J 2021;23:88. [PMID: 34169439 DOI: 10.1208/s12248-021-00619-4] [Reference Citation Analysis]
30 Akpalu D, Newman G, Brice M, Powell M, Singh R, Quarshie A, Ofili E, Fonger J, Chronos N, Feldman D. Matrix Signaling Subsequent to a Myocardial Infarction: A Proteomic Profile of Tissue Factor Microparticles. JACC Basic Transl Sci 2017;2:529-42. [PMID: 30062169 DOI: 10.1016/j.jacbts.2017.04.004] [Reference Citation Analysis]
31 See Hoe LE, Foster SR, Wendt L, Patel HH, Headrick JP, Peart JN. Regulation of the β -Adrenergic Receptor Signaling Pathway in Sustained Ligand-Activated Preconditioning. J Pharmacol Exp Ther 2019;369:37-46. [DOI: 10.1124/jpet.118.251660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Sherpa RT, Fiore C, Moshal KS, Wadsworth A, Rudokas MW, Agarwal SR, Harvey RD. Mitochondrial A-kinase anchoring proteins in cardiac ventricular myocytes. Physiol Rep 2021;9:e15015. [PMID: 34514737 DOI: 10.14814/phy2.15015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Stöckigt F, Brixius K, Lickfett L, Andrié R, Linhart M, Nickenig G, Schrickel JW. Total beta-adrenoceptor knockout slows conduction and reduces inducible arrhythmias in the mouse heart. PLoS One 2012;7:e49203. [PMID: 23133676 DOI: 10.1371/journal.pone.0049203] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
34 Jung G, Fajardo G, Ribeiro AJ, Kooiker KB, Coronado M, Zhao M, Hu DQ, Reddy S, Kodo K, Sriram K, Insel PA, Wu JC, Pruitt BL, Bernstein D. Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation. FASEB J 2016;30:1464-79. [PMID: 26675706 DOI: 10.1096/fj.15-280982] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
35 Ibragimova AA, Emelina EI, Gendlin GE, Nikitin IG. ABILITY TO PREVENT AND TREAT THE CARDIOVASCULAR SYSTEM DAMAGES, CAUSED BY THE USE OF ANTI-CANCER DRUGS. Medical Journal of the Russian Federation 2018;24:316-23. [DOI: 10.18821/0869-2106-2018-24-6-316-323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]